GeneSight Mental Health Monitor Media Kit
Americans’ anxiety toward upcoming Presidential election has increased; mental health expert encourages treatment for those who are impacted
Phase II of GeneSight® Mental Health Monitor Election Survey from Myriad Genetics Shows 41% of Americans Report Feeling Anxious as the Election Draws Closer
The GeneSight Mental Health Monitor is a nationwide survey conducted online by ACUPOLL Precision Research, Inc. between February 16-21, 2024 among a representative sample (n=1000) of U.S. adults age 18+. The margin of error in survey results for the total base population at a 95% confidence interval is +/- 3%. A nationally representative sample of adults aged 18 years or older was recruited and balanced to match U.S. Census quotas across five primary metrics (i.e., age, gender, income, region, ethnicity).
In addition to the nationally representative sample, a statistically reliable sample was desired of respondents who were self-reported as being diagnosed by a medical professional with depression or anxiety. The study also used mental health screening instruments, the Patient Health Questionnaire-2 (PHQ-2) for depression, and the General Anxiety Disorder (GAD-2) for anxiety, to better understand this population.
ACUPOLL has more than 30 years of experience conducting statistically valid research through careful recruiting and quality control measures.
Previous releases
Nearly Half of Americans Say They’ve Lost Time in Their Lives Due to Poor Mental Health, According to the GeneSight Mental Health Monitor
April 17, 2024
80% of people diagnosed with anxiety, depression report losing years or decades of time
Nearly Half of BIPOC Individuals Say They Are Dissatisfied with Their Mental Health, according to Myriad Genetics Nationwide Survey
July 14, 2023
BIPOC respondents were less likely to seek help than the general population.
93% of Adults who Identify as LGBTQ+ Have Used Coping Mechanisms or Addictive Behaviors to Manage their Mental Health, according to Myriad Genetics Nationwide Survey
June 5, 2023
Nearly twice as many LGBTQ+ respondents say they are currently diagnosed with depression and/or anxiety than the general population.
Is “Manning Up” Bringing Men Down?
June 5, 2023
Men are less likely to have a trusted mental healthcare provider than females.
77% of Americans have used addictive behaviors or unhealthy coping mechanisms to manage their mental health, according to Myriad Genetics nationwide survey
April 19, 2023
Medication failure leads 45% of respondents with depression and/or anxiety to turn to unhealthy coping mechanism
GeneSight Mental Health Monitor Reveals Gap on the Front Line of Mental Health Care
November 17, 2022
Survey finds primary care providers wish patients would raise mental health concerns so they can provide better overall care.
2 Out of 3 Women With Depression or Anxiety Say They’ve Reached Their “Breaking Point,” Yet More than Half Wait a Year Before Seeking Treatment
April 26, 2022
Six in 10 of the women surveyed with depression or anxiety diagnosis say they have been ignored or dismissed by family, friends, and/or partners about their mental health concerns
New Year’s Resolutions: Americans Say Body & Mind Equally Important in Theory but Not in Practice, According to GeneSight® Mental Health Monitor Nationwide Survey
December 15, 2021
Now is the time when people start to think of new year’s resolutions to improve their health. For many, the focus is on physical goals like losing weight or exercising more. A nationwide survey suggests that many may want to consider adding mental health resolutions to their list.
The New Generation Gap: Nationwide Survey Finds Different Perspectives on Anxiety Between Parents, Young Adults
November 23, 2021
GeneSight Mental Health Monitor finds many parents struggle to know the difference between teenage behavior and a mental health challenge
One of the biggest issues parents of teenagers may face is determining if their child is
experiencing a mental health challenge or ordinary “growing pains.”
Americans’ anxiety impacted by the ongoing pandemic, yet 1 in 5 say they won’t seek treatment according to the GeneSight® Mental Health Monitor nationwide survey
October 11, 2021
Many Americans are experiencing anxiety symptoms as a result of the pandemic. Yet, one in five say they won’t seek treatment for mental health conditions and others say they won’t get help until these symptoms take a toll in their lives.
Only 8% of people remain hopeful after depression medication fails them, according to GeneSight® Mental Health Monitor nationwide survey
September 8, 2021
Depression medication trial and error is far too common – and may result in additional
mental health challenges.
New research reveals most Americans can’t identify the symptoms of depression
July 28, 2021
GeneSight® Mental Health Monitor finds large gap between what Americans think and what they actually know about recognizing depression
Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in genetic testing and precision medicine,
today announced results from a recent nationwide poll, the GeneSight® Mental Health Monitor.
Depression Disconnect: GeneSight® Mental Health Monitor Shows Misunderstanding of Depression and Treatment
April 28, 2021
New poll shows 83% of people with depression agree life would be easier if others could understand their depression
In a new nationwide poll, the GeneSight® Mental Health Monitorfound that 83% of people with depression agree that life would be easier if others could understand their depression. Yet, most people who have not experienced depression may not be able to understand the challenges, including its treatment.